Status:
RECRUITING
Evaluation of Concordance Between Exhaled Air Test (eBAM-CoV) and RT-PCR to Detect SARS-CoV-2
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Collaborating Sponsors:
University of Nimes
brains' laboratory sas, FRANCE
Conditions:
SARS-CoV-2 Infection
COVID-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
During the COVID-19 pandemic, testing primarily relied on the use of nasopharyngeal swabs to detect the SARS-CoV-2 virus, responsible for the disease. However, this technique has several limitations, ...
Eligibility Criteria
Inclusion
- Adult male or female patients over 18 years of age (≥)
- Suspected of being infected with COVID-19 (symptomatic or contact case) and consulting for RT-PCR screening.
Exclusion
- Inability to understand the procedures to use the device
- Patient participating in an another interventional study
- Patient in exclusion period determined by another study
- Patient under court protection or guardianship
- Patient/trusted person/legal representative/family member for whom it is impossible to give informed information.
- Pregnant, parturient or breast-feeding patient
Key Trial Info
Start Date :
January 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06099795
Start Date
January 1 2025
End Date
June 1 2026
Last Update
March 24 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Laboratoire Alphabio, Hôpital Européen Marseille
Marseille, France, 13003
2
CHU de NIMES
Nîmes, France, 30029